New antibody discovery platform can delve deeper into Alzheimer’s and Parkinson’s
A new antibody discovery platform can delve deeper into the mechanisms underlying the processes behind Alzheimer's and Parkinson’s diseases, say researchers.
A new antibody discovery platform can delve deeper into the mechanisms underlying the processes behind Alzheimer's and Parkinson’s diseases, say researchers.
We are part of a world where millions have been suffering from preventable diseases because of the lack of access to healthcare.
The Liver Foundation, West Bengal, a non-profit has developed both IILDS and JCMLRI.
Advertisement